Q4 2023 Hansa Biopharma AB Earnings Call Transcript
And welcome to the Hansa Biopharma conference call covering the fourth quarter and full year 2023 earnings results. Today's call is being recorded (Operator Instructions)
¸ -
Speakers, please again Thank you, operator, and good afternoon. Good morning, and welcome to the Hansa Biopharma conference call to review year-end results for 2023. I'm Søren Tulstrup, CEO of Hansa Biopharma.
Joining me today is our Chief Commercial Officer and US President, Matt Shaulis; our Chief Financial Officer, Donato Spota; and our Chief Scientific Officer, Hitto Kaufmann, to join hands of December last year. We're thrilled to welcome here to the Hans team at this pivotal time with over 20 years' experience in research, development and advancement of science in both large pharma and small biotech organizations, eSports, solid development of our scientific platform and the advancement of our exciting pipeline of our candidates as Head of Investor Relations Klaus Sindahl, is also with us.
Today
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |